Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI)

被引:1667
作者
Assmus, B
Schächinger, V
Teupe, C
Britten, M
Lehmann, R
Döbert, N
Grünwald, F
Aicher, A
Urbich, C
Martin, H
Hoelzer, D
Dimmeler, S
Zeiher, AM
机构
[1] Univ Frankfurt, Dept Mol Cardiol, D-60590 Frankfurt, Germany
[2] Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany
[3] Univ Frankfurt, Dept Nucl Med, D-60590 Frankfurt, Germany
[4] Univ Frankfurt, Dept Hematol, D-60590 Frankfurt, Germany
关键词
myocardial infarction; cells; remodeling; transplantation;
D O I
10.1161/01.CIR.0000043246.74879.CD
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Experimental studies suggest that transplantation of blood-derived or bone marrow-derived progenitor cells beneficially affects postinfarction remodeling. The safety and feasibility of autologous progenitor cell transplantation in patients with ischemic heart disease is unknown. Methods and Results-We randomly allocated 20 patients with reperfused acute myocardial infarction (AMI) to receive intracoronary infusion of either bone marrow-derived (n=9) or circulating blood-derived progenitor cells (n=11) into the infarct artery 4.3+/-1.5 days after AMI. Transplantation of progenitor cells was associated with a significant increase in global left ventricular ejection fraction from 51.6+/-9.6% to 60.1+/-8.6% (P=0.003), improved regional wall motion in the infarct zone (-1.5+/-0.2 to -0.5+/-0.7 SD/chord; P<0.001), and profoundly reduced end-systolic left ventricular volumes (56.1+/-20 mL to 42.2+/-15.1 mL; P=0.01) at 4-month follow-up. In contrast, in a nonrandomized matched reference group, left ventricular ejection fraction only slightly increased from 51+/-10% to 53.5+/-7.9%, and end-systolic volumes remained unchanged. Echocardiography revealed a profound enhancement of regional contractile function (wall motion score index 1.4+/-0.2 at baseline versus 1.19+/-0.2 at follow-up; P<0.001). At 4 months, coronary blood flow reserve was significantly (P<0.001) increased in the infarct artery. Quantitative F-18-fluorodeoxyglucose-positron emission, tomography analysis revealed a significant (P<0.01) increase in myocardial viability in the infarct zone. There were no differences for any measured parameter between blood-derived or bone marrow-derived progenitor cells. No signs of an inflammatory response or malignant arrhythmias were observed. Conclusions-In patients with AMI, intracoronary infusion of autologous progenitor cells appears to be feasible and safe and may beneficially affect postinfarction remodeling processes.
引用
收藏
页码:3009 / 3017
页数:9
相关论文
共 32 条
[1]   Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; A comparative study using different protocols [J].
Bax, JJ ;
Veening, MA ;
Visser, FC ;
vanLingen, A ;
Heine, RJ ;
Cornel, JH ;
Visser, CA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (01) :35-41
[2]   HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J].
Dimmeler, S ;
Aicher, A ;
Vasa, M ;
Mildner-Rihm, C ;
Adler, K ;
Tiemann, M ;
Rütten, H ;
Fichtlscherer, S ;
Martin, H ;
Zeiher, AM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :391-397
[3]   THE USE OF BIPLANE ANGIOCARDIOGRAPHY FOR THE MEASUREMENT OF LEFT VENTRICULAR VOLUME IN MAN [J].
DODGE, HT ;
SANDLER, H ;
BALLEW, DW ;
LORD, JD .
AMERICAN HEART JOURNAL, 1960, 60 (05) :762-776
[4]   Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia [J].
Fuchs, S ;
Baffour, R ;
Zhou, YF ;
Shou, M ;
Pierre, A ;
Tio, FO ;
Weissman, NJ ;
Leon, MB ;
Epstein, SE ;
Kornowski, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (06) :1726-1732
[5]   Hematopoietic vascular and cardiac fates of bone marrow-derived stem cells [J].
Hirschi, KK ;
Goodell, MA .
GENE THERAPY, 2002, 9 (10) :648-652
[6]   Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells [J].
Jackson, KA ;
Majka, SM ;
Wang, HG ;
Pocius, J ;
Hartley, CJ ;
Majesky, MW ;
Entman, ML ;
Michael, LH ;
Hirschi, KK ;
Goodell, MA .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (11) :1395-1402
[7]   Pluripotency of mesenchymal stem cells derived from adult marrow [J].
Jiang, Yuehua ;
Jahagirdar, Balkrishna N. ;
Reinhardt, R. Lee ;
Schwartz, Robert E. ;
Keene, C. Dirk ;
Ortiz-Gonzalez, Xilma R. ;
Reyes, Morayma ;
Lenvik, Todd ;
Lund, Troy ;
Blackstad, Mark ;
Du, Jingbo ;
Aldrich, Sara ;
Lisberg, Aaron ;
Low, Walter C. ;
Lergaespada, David A. ;
Verfaillie, Catherine M. .
Nature, 2002, 418 (6893) :41-49
[8]   Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization [J].
Kalka, C ;
Masuda, H ;
Takahashi, T ;
Kalka-Moll, WM ;
Silver, M ;
Kearney, M ;
Li, T ;
Isner, JM ;
Asahara, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3422-3427
[9]  
Kawamoto A, 2001, CIRCULATION, V103, P634
[10]   Coronary physiology revisited - Practical insights from the cardiac catheterization laboratory [J].
Kern, MJ .
CIRCULATION, 2000, 101 (11) :1344-1351